Ayurveda GCP Guidelines: Need for freedom from RCT ascendancy in favor of whole system approach

Journal of Ayurveda and Integrative Medicine

Volumn 2, Issue 1, 2011, Pages 1-4

  Patwardhan, Bhushan ^a  

^a Institute of Ayurveda and Integrative Medicine   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AHARA; AUSHADHI; AYURVEDIC DRUG; METHOTREXATE; PANCHAKARMA; UNCLASSIFIED DRUG; VIHARA;

AYURVEDA; BIOMEDICINE; CLINICAL RESEARCH; DIET; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GOOD CLINICAL PRACTICE; HEALTH CARE SYSTEM; HERBAL MEDICINE; LIFE EXPECTANCY; LIFESTYLE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL ETHICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS;

EID: 79953818855     PISSN: 09759476     EISSN: 09762809     Source Type: Journal    
DOI: 10.4103/0975-9476.78175     Document Type: Editorial

References (25)

1. Good Clinical Practices, Guidelines for Clinical Trials on Ayurveda, Siddha, Unani Medicines and Other Traditional Medicines based on CDSCO Document on GCP Guidelines for Clinical Trials on Pharmaceutical Products. Department of AYUSH Ministry of Health & Family Welfare, Government of India, Indian Red Cross Society Building, New Delhi - 11001. Available from: http://www. indianmedicine.nic.in.
2. http://pharmexcil.org/data/media-files/Ayushdeptissues-media-file-699. pdf.
3. Agarwal SP. Director General of Health Services and Chairman, DTAB. Available from: http://cdsco.nic.in/html/GCP.htm.
4. Miller FG, Joffe S. Equipoise and the Dilemma of Randomized Clinical Trials. N Engl J Med 2011;364:476-80.
5. Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010;363:809-19.
6. Hankey A. Test of System's Analysis underlying the Scientific Theory of Ayurveda's Tridosha. J Altern Complement Med 2005;11:385-90. (Pubitemid 40994569)
7. Patwardhan B, Joshi K, Chopra A. Classification of Human Population based on HLA Gene Polymorphism and the Concept of Prakriti in Ayurveda. J Altern Complement Med 2005;11:349-53.
8. Aggarwal S. EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proc Natl Acad Sci USA 2010;107:18961-6.
9. Ghodke Y, Joshi K, Patwardhan B. (2009) Traditional Medicine to Modern Pharmacogenomics: Ayurveda Prakriti Type and CYP2C19 Gene Polymorphism Associated with the Metabolic Variability Evid Based Complement Alt Med eCAM Advance Access published online.
10. Patwardhan B, Bodeker G. Ayurvedic Genomics - Establishing a genetic basis for mind body typologies. J Alt Compl Med 2008;14:571-6. (Pubitemid 351873380)
11. Joshi K, Ghodke Y, Shintre P. Traditional medicine and genomics. J Ayurveda Integrat Med 2010;1:26-32.
12. Prakash B, Parikh PM, Pal SK. Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. J Ayurveda Integr Med 2010;1:215-8.
13. Furst DE, Venkatraman MM, Krishna Swamy BG, McGann M, Booth-Laforce C, Ram Manohar P, et al. Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritis. Ann Rheum Dis 2011;70:392-3.
14. Chopra A, Saluja M, Tillu G, Venugopalan A, Sarmukaddam S, Raut AK, et al. "A Randomized Controlled Exploratory Evaluation of Standardized Ayurvedic Formulations in Symptomatic Osteoarthritis Knees: A Government of India NMITLI Project," Evidence-Based Complement Alternat Med 2011;2011:724291.
15. Sarmukaddam S, Chopra A, Tillu G. Efficacy and safety of Ayurvedic medicines: Recommending equivalence trial design and proposing safety index. Int J Ayurveda Res 2010;1:175-80.
16. Chopra A, Saluja M, Tillu G. Ayurveda-modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis. J Ayurveda Integr Med 2010;1:190-8.
17. Chaudhary A, Singh N, Kumar N. Pharmacovigilance: Boon for the safety and efficacy of ayuvedic formulations. J Ayurveda Integr Med 2010;1:251-6.
18. Shankar D. Conceptual framework for new models of integrative medicine. J Ayurveda Integr Med 2010;1:3-5.
19. Fønnebø V, Grimsgaard S, Walach H. Researching complementary and alternative treatments - the gatekeepers are not at home. BMC Med Res Methodol 2007;7:7.
20. Hegde BM. Unconventional wisdom in medicine. J Ind Acad Clin Med 2007;8:294-6. (Pubitemid 350271659)
21. Vaidya RA, Vaidya AB, Patwardhan B, Tillu G, Rao Y. Ayurvedic pharmacoepidemiology: A proposed new discipline. J Asso Physicians India 2003;51:528. (Pubitemid 41315539)
22. Tillu G. Workshop on a CONSORT statement for Ayuveda. J Ayurveda Integr Med 2010;1:158-9.
23. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
24. Valiathan MS. Towards Ayurvedic Biology. A Decadal Vision Document - 2006. Indian Academy of Sciences, Bangalore, 2007.
25. Ritenbaugh C, Hammerschlag R, Calabrese C, Mist S, Aickin M, Sutherland E, et al. A Pilot Whole Systems Clinical Trial of Traditional Chinese Medicine and Naturopathic Medicine for the Treatment of Temporomandibular Disorders. J Altern Complement Med 2008;14:475-87. (Pubitemid 351873384)